In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic ...

A common blood pressure drug may help a major class of cancer therapies work far better than expected. A widely prescribed ...

Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...

A recent study found that GLP-1 medications like Ozempic and Wegovy may help improve breast cancer survival rates among women ...

Former Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing him to live longer and with less pain.

The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreatic cancer drug daraxonrasib.

By Deena Beasley and Nancy Lapid May 14 (Reuters) - U.S. cancer centers are scrambling to enroll patients in an early access ...

When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer ...

Former Sen. Ben Sasse of Nebraska reveals an experimental cancer drug helped shrink his tumors by 76% after a stage 4 metastatic pancreatic cancer diagnosis.

Several studies have served up tantalizing hints about the drugs’ potential cancer prevention benefits, but other results ...